Log in

OTCMKTS:HDII - Hypertension Diagnostics Stock Price, Forecast & News

$0.0050
0.00 (0.00 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$0.00
Now: $0.01
$0.01
50-Day Range
$0.00
MA: $0.01
$0.02
52-Week Range
$0.00
Now: $0.01
$0.04
Volume3.41 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Minnetonka, Minnesota.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:HDII
CUSIP44914V104
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees3
Next Earnings DateN/A
OptionableNot Optionable

Receive HDII News and Ratings via Email

Sign-up to receive the latest news and ratings for HDII and its competitors with MarketBeat's FREE daily newsletter.


Hypertension Diagnostics (OTCMKTS:HDII) Frequently Asked Questions

What is Hypertension Diagnostics' stock symbol?

Hypertension Diagnostics trades on the OTCMKTS under the ticker symbol "HDII."

Has Hypertension Diagnostics been receiving favorable news coverage?

Media coverage about HDII stock has been trending somewhat positive recently, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Hypertension Diagnostics earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Hypertension Diagnostics.

What other stocks do shareholders of Hypertension Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hypertension Diagnostics investors own include Integrated Cannabis (ICNAF), Hemp (HEMP), GASTAR EXPL INC/SH (GST), Zynerba Pharmaceuticals (ZYNE), Tonix Pharmaceuticals (TNXP), NXT-ID (NXTD), New Age Beverages (NBEV), Genocea Biosciences (GNCA), Cypress Semiconductor (CY) and Celldex Therapeutics (CLDX).

Who are Hypertension Diagnostics' key executives?

Hypertension Diagnostics' management team includes the folowing people:
  • Mr. Kenneth W. Brimmer, CEO, Pres, CFO & Director (Age 64)
  • Mr. Joseph D'Albero, Exec.
  • Mr. Maury Taylor, Exec. Director

How do I buy shares of Hypertension Diagnostics?

Shares of HDII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Hypertension Diagnostics' stock price today?

One share of HDII stock can currently be purchased for approximately $0.01.


MarketBeat Community Rating for Hypertension Diagnostics (OTCMKTS HDII)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  87
MarketBeat's community ratings are surveys of what our community members think about Hypertension Diagnostics and other stocks. Vote "Outperform" if you believe HDII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HDII will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Do You Need a Fiduciary?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel